Predicting the pathogenicity of protein coding mutations using Natural Language Processing
暂无分享,去创建一个
Sanjay Kumar | Hammad Naveed | Naeem Rehmat | Hammad Farooq | Sibt ul Hussain | Hammad Naveed | Hammad Farooq | Sanjay Kumar | Naeem Rehmat | Sibt ul Hussain
[1] C. Sander,et al. Predicting the functional impact of protein mutations: application to cancer genomics , 2011, Nucleic acids research.
[2] Tom R. Gaunt,et al. Predicting the Functional, Molecular, and Phenotypic Consequences of Amino Acid Substitutions using Hidden Markov Models , 2012, Human mutation.
[3] Adam Godzik,et al. e-Driver: a novel method to identify protein regions driving cancer , 2014, Bioinform..
[4] J. Miller,et al. Predicting the Functional Effect of Amino Acid Substitutions and Indels , 2012, PloS one.
[5] Karen Spärck Jones. A statistical interpretation of term specificity and its application in retrieval , 2021, J. Documentation.
[6] Mingming Jia,et al. COSMIC: somatic cancer genetics at high-resolution , 2016, Nucleic Acids Res..
[7] Ricardo Villamarín-Salomón,et al. ClinVar: public archive of interpretations of clinically relevant variants , 2015, Nucleic Acids Res..
[8] Jae-Hwan Jhong,et al. Erratum to: Meta-analytic support vector machine for integrating multiple omics data , 2017, BioData Mining.
[9] R. Gibbs,et al. Comparison and integration of deleteriousness prediction methods for nonsynonymous SNVs in whole exome sequencing studies. , 2015, Human molecular genetics.
[10] David Tamborero,et al. OncodriveCLUST: exploiting the positional clustering of somatic mutations to identify cancer genes , 2013, Bioinform..
[11] Laura Inés Furlong,et al. Challenges in the association of human single nucleotide polymorphism mentions with unique database identifiers , 2011, BMC Bioinformatics.
[12] K. Flaherty,et al. Combined BRAF and MEK inhibition in melanoma with BRAF V600 mutations. , 2012, The New England journal of medicine.
[13] Moriah H Nissan,et al. OncoKB: A Precision Oncology Knowledge Base. , 2017, JCO precision oncology.
[14] Joaquín Dopazo,et al. A Pan-Cancer Catalogue of Cancer Driver Protein Interaction Interfaces , 2015, PLoS Comput. Biol..
[15] C. Sander,et al. 3D clusters of somatic mutations in cancer reveal numerous rare mutations as functional targets , 2017, Genome Medicine.
[16] Elizabeth M. Smigielski,et al. dbSNP: the NCBI database of genetic variation , 2001, Nucleic Acids Res..
[17] Min Huang,et al. Molecularly targeted cancer therapy: some lessons from the past decade. , 2014, Trends in pharmacological sciences.
[18] D. Hanahan,et al. Hallmarks of Cancer: The Next Generation , 2011, Cell.
[19] Zhiyong Lu,et al. tmVar 2.0: integrating genomic variant information from literature with dbSNP and ClinVar for precision medicine , 2018, Bioinform..
[20] N. McGranahan,et al. The causes and consequences of genetic heterogeneity in cancer evolution , 2013, Nature.
[21] K. Garber. In a major shift, cancer drugs go 'tissue-agnostic'. , 2017, Science.
[22] Yifan Peng,et al. BioSentVec: creating sentence embeddings for biomedical texts , 2018, 2019 IEEE International Conference on Healthcare Informatics (ICHI).
[23] P. Ng,et al. SIFT missense predictions for genomes , 2015, Nature Protocols.
[24] P. A. Futreal,et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. , 2012, The New England journal of medicine.
[25] Cathy H. Wu,et al. UniProt: the Universal Protein knowledgebase , 2004, Nucleic Acids Res..
[26] Michael Cariaso,et al. SNPedia: a wiki supporting personal genome annotation, interpretation and analysis , 2011, Nucleic Acids Res..
[27] Jana Marie Schwarz,et al. MutationTaster2: mutation prediction for the deep-sequencing age , 2014, Nature Methods.
[28] Lilia M. Iakoucheva,et al. MutPred2: inferring the molecular and phenotypic impact of amino acid variants , 2017, bioRxiv.
[29] Mauno Vihinen,et al. VariBench: A Benchmark Database for Variations , 2013, Human mutation.
[30] S. Gabriel,et al. Discovery and saturation analysis of cancer genes across 21 tumor types , 2014, Nature.
[31] Gill Bejerano,et al. M-CAP eliminates a majority of variants of uncertain significance in clinical exomes at high sensitivity , 2016, Nature Genetics.
[32] Li Ding,et al. Protein-structure-guided discovery of functional mutations across 19 cancer types , 2016, Nature Genetics.
[33] Gustavo Glusman,et al. Clinical applications of sequencing take center stage , 2013, Genome Biology.
[34] Tapio Salakoski,et al. Distributional Semantics Resources for Biomedical Text Processing , 2013 .
[35] C. Atreya,et al. Combined BRAF and MEK Inhibition With Dabrafenib and Trametinib in BRAF V600-Mutant Colorectal Cancer. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[36] E. Boerwinkle,et al. dbNSFP v3.0: A One‐Stop Database of Functional Predictions and Annotations for Human Nonsynonymous and Splice‐Site SNVs , 2016, Human mutation.
[37] Gerard Salton,et al. Automatic Information Organization And Retrieval , 1968 .
[38] S. Henikoff,et al. Amino acid substitution matrices from protein blocks. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[39] Steven J. M. Jones,et al. CIViC is a community knowledgebase for expert crowdsourcing the clinical interpretation of variants in cancer , 2017, Nature Genetics.
[40] Leyla Isik,et al. Cancer-specific high-throughput annotation of somatic mutations: computational prediction of driver missense mutations. , 2009, Cancer research.
[41] Bartek Wilczynski,et al. Biopython: freely available Python tools for computational molecular biology and bioinformatics , 2009, Bioinform..
[42] Zhiyong Lu,et al. PubTator: a web-based text mining tool for assisting biocuration , 2013, Nucleic Acids Res..
[43] P. Bork,et al. A method and server for predicting damaging missense mutations , 2010, Nature Methods.